BARINTHUS BIOTHERAPEUTICS PLC Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2024-03-20
- BARINTHUS BIOTHERAPEUTICS PLC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-12-31 was $0.00.
- BARINTHUS BIOTHERAPEUTICS PLC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-09-30 was $0.00.
- BARINTHUS BIOTHERAPEUTICS PLC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-06-30 was $2.36M, a 21390.91% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2022-03-31 was $36.00K, a 227.27% increase year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $2.40M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-20 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $0.00 derived: sum of 2 quarters · filed 2024-03-20 | $2.36M derived: sum of 3 quarters · filed 2024-03-20 | $2.40M 10-K · filed 2024-03-20 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.36M derived: sum of 2 quarters · filed 2023-11-09 | $2.40M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.40M 10-Q · filed 2023-08-10 | $46.00K 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $36.00K 10-Q · filed 2022-05-11 | ||||
| 2021-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $22.00K 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $11.00K 10-Q · filed 2021-06-14 | ||||
| 2020-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $19.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $10.00K 10-Q · filed 2021-06-14 |